| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $195.5M | +5.5% | +7.0% |
| Gross Profit | $58.2M | +7.9% | +6.6% |
| R&D Expense | $210K | -21.9% | -12.9% |
| SG&A Expense | $33.5M | -15.9% | -13.9% |
| Operating Income | $20.4M | +141.8% | +71.9% |
| Pre-tax Income | $17.0M | +305.8% | +88.2% |
| Income Tax | $3.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $27.8M | +39.3% | +36.6% |
| Accounts Receivable | $174.8M | +9.4% | +21.3% |
| Inventory | $14.8M | -2.1% | +2.0% |
| Current Assets | $237.5M | +11.3% | +22.8% |
| Total Assets | $596.3M | +4.4% | +8.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $843K | — | — |
| Capital Expenditures | $18.5M | — | — |
| Investing Cash Flow | -$19.0M | — | — |
| Financing Cash Flow | $26.2M | — | — |
| Free Cash Flow | -$17.7M | — | — |
| +257.2% |
| +45.0% |
| Net Income | $13.1M | +334.5% | +104.8% |
| EPS (Basic) | $0.42 | +320.0% | +100.0% |
| EPS (Diluted) | $0.41 | +310.0% | +105.0% |
| $125.8M |
| -2.1% |
| +9.2% |
| Long-term Debt | $202.3M | +6.8% | +6.6% |
| Total Liabilities | $368.4M | +3.8% | +6.4% |
| Stockholders' Equity | $227.4M | +5.4% | +10.8% |